Page 253 - Traité de chimie thérapeutique 6 Médicaments antitumoraux

10 DACARBAZINE ET TEMOZOLOMIDE 209

SHEALY Y.F. et al., Synthesis and biological activities of 5-amlnoimidazoles and 5-tria-
zeneimidazoles, J. Pharm. Sei., 1970, 59 1533-1558
ZAMBITO A. J. et al., 4(or 5)-(3,3-dimethyl-1-triazeno)imidazole-5 (or4) carboxamide. An
improved procedure adaptable to large-scale production, Nucleic acid. Chem., 1978,
1, 3-12.
CARACTÉRISTIQUES PHYSICOCHIMIQUES
SHEALY Y.F. et al., lmidazoles Il. 5(or4)-monosubstituted triazenoimidazole-4 (or 5) car-
boxamide, J. Med. Chem., 1966, 9, 34-38.
VAUGHAN K., The effect of electron-withdrawing substituants on the tautomerism
between 1-aryl-3-methyltriazenes and 3-aryl-1-methyltriazenes, J. Chem. Soc. Perkin
Trans, II, 1977, 17-20
KANG U.G., SHECHTER H., Insertion reactions of 4H-imidazolylidenes into C-H bonds
of alcohols, J. Amer. Chem. Soc., 1978, 100, 651-652.
FREEMAN H.C., HUTCHINSON N.D., The crystal structure of the anti-tumor agent 5-
(3,3-dimethyl-1-triazenyl)imidazole-4-carboxamide (NSC-45388), Acta Cryst., 1979,
sect. B 35, 2051-2054.
ROSENFELD M.N., WIDDOWSON D.A., A mild and efficient method of aromatic fluori-
nation, J. Chem. Soc. Chem. Comm., 1979, 914-916.
WASILEWSKA L., Polarographic determination of dacarbazine, Acta Pol. Pharm. 1979,
36, 451-455 in Chem. abstr, 1980, 93, 13144.
HORTON J. K., STEVENS M. F J, Search for drug interaction between the antitumour
agent DTIC and other cytotoxic agents, J. Pharm. Pharmacol., 1979, 31 (supp.), 64P.
SATYAMURTHY N., BARRIO J. R., Cation exchange resln (hydrogen form) assisted
decomposition of 1-aryl-3,3-dialkyltriazenes. A mild and efficient method for the syn-
thesis of aryl iodides, J. Org. Chem., 1983, 48, 4394-4396.
GOLDING B Tet al., pH dependence of rotational barriers about the N(3)-N(2) bond in 5-
(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide evaluated by 'H NMR spectros-
copy, J. Chem. Res., (S)1984, 130-131.

CONTRÔLE, DOSAGES DANS LES LIQUIDES BIOLOGIQUES
FIORE D. et al., Simultaneous determination of dacarbazine, its photolytic degradation
product, 2-azahypoxanthine, and the metabolite 5-aminoimidazole-4-carboxamide in
plasma and urine by high-pressure liquid chromatography, Antimicrob. agents and
Chemother., 1985, 27, 977-979.
PHARMACOCINÉTIQUE
LOO T. L. et al., Pharmacological studles of the antitumor agent 5-(dimethyltriazeno)imi-
dazole-4-carboxamide, Cancer Res., 1968, 28, 2448-2453.
SKIBBA J. L et al., N-demethylation of the antineoplastic agent 4(5)-(3,3-dimethyl-
1triazeno)imidazole-5(4)-carboxamide by rats and man, Cancer research, 1970, 30,
147-150.
HOUSHOLDER G. E., LOO T. L., Disposition of 5-(3,3-diméthy!-1-triazeno) imidazole-4-
carboxamide, a new antitumor agent, J. Pharmacol. & exp. ther., 1971, 179, 386-395.